November 06, 2019
Oncopeptides to Highlight Data from Melflufen Clinical Program in Multiple Myeloma and AL Amyloidosis in Six Presentations at ASH Annual Meeting 2019
Media
November 05, 2019
Strongbridge Biopharma plc Announces CEO Transition Plan and Provides Preliminary Third Quarter 2019 Financial Results and Corporate Updates
October 31, 2019
Q3 2019 General Market Overview
October 30, 2019
BONESUPPORT HOLDING AB (publ) – Q3 2019 Interim Report – invitation to conference call and webcast
October 29, 2019
Strongbridge Biopharma plc to Host Third Quarter 2019 Financial Results Conference Call on November 7, 2019
October 29, 2019
Targovax ASA: Invitation to presentation of Targovax’s third quarter 2019 results, Thursday 7 November
October 24, 2019
Orexo Interim Report Q3 2019
October 22, 2019
GenSight Biologics Reports its Cash Position as of September 30, 2019 and Provides Operational Update
October 18, 2019
Nordic Nanovector – Private placement successfully completed
October 17, 2019
Strongbridge Biopharma plc Presents KEVEYIS® (dichlorphenamide) Primary Periodic Paralysis (PPP) Data at the 2019 American Association of Neuromuscular & Electrodiagnostic Medicine Annual Meeting